Skip to content
healthcare.dev

Fulvestrant

NDC 70860-211, fulvestrant, injection, solution, from Athenex Pharmaceutical Division, LLC..

Product NDC
70860-211
Status
Listed
Labeler
Athenex Pharmaceutical Division, LLC.
Dosage form
INJECTION, SOLUTION
Route
INTRAMUSCULAR
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA211422
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/70860-211 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • FULVESTRANT50 mg/mL

Pharmacologic classes

Estrogen Receptor Antagonist [EPC]; Estrogen Receptor Antagonists [MoA]; Selective Estrogen Receptor Modulators [MoA]

Package NDCNDC-11Package
70860-211-74708600211742 SYRINGE, GLASS in 1 CARTON (70860-211-74) / 5 mL in 1 SYRINGE, GLASS (70860-211-41)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/8ed06e0e-c17b-4c71-8d03-888bcde4a638
  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=70860-211

Use it

Look up 70860-211 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/70860-211 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 70860-211. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.